ALS drug trials face setbacks but offer glimmers of hope
FierceBiotech - 07-Jan-2025Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Join the club for FREE to access the whole archive and other member benefits.
Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Susannah Morgan was the first to undergo this surgery in Scotland
Clinical success and FDA submission mark pivotal steps in redefining nerve regeneration solutions
New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
Experts discuss on the ethics and feasibility of body transplants in the near future
No resources found!
No blog posts found!